# EDGAR Filing Document

**Accession Number:** 0001869105
**File Stem:** 0001213900-25-062226
**Filing Date:** 2025-7
**Character Count:** 3552
**Document Hash:** 14f2e1e65e71443a865f153d9732d906
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-062226.hdr.sgml**: 20250903

**ACCESSION NUMBER**: 0001213900-25-062226

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250709

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Helix Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0001869105
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 256 E. GRAND AVENUE, SUITE 104
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080
- **BUSINESS PHONE:** 857 702 0377

**MAIL ADDRESS:**
- **STREET 1:** 256 E. GRAND AVENUE, SUITE 104
- **CITY:** SOUTH SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94080

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Helix Acquisition Corp. II
- **DATE OF NAME CHANGE:** 20210623
**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TheRas, Inc.
- **CENTRAL INDEX KEY:** 0002022953
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3160 PORTER DRIVE SUITE 250
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94304
- **BUSINESS PHONE:** 6504057021

**MAIL ADDRESS:**
- **STREET 1:** 3160 PORTER DRIVE SUITE 250
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94304

---

| | |
|:---|:---|
| **Helix Acquisition Corp. II** <br> 200 Clarendon Street, 52<sup>nd</sup> Floor <br> Boston, MA 02116 | **TheRas, Inc.** <br> 256 E. Grand Avenue, Suite 104 <br> South San Francisco, CA 94080 |

---

July 9, 2025

**<u>VIA EDGAR</u>**

United States Securities and Exchange Commission<br> Division of Corporation Finance<br> Office of Life Sciences

100 F Street NE<br> Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Acceleration Request for Helix Acquisition Corp. II and TheRas, Inc.** |
|  | **Registration Statement on Form S-4** |
|  | **File No. 333-288222** |

---

---

| | |
|:---|:---|
| **Requested Date:** | **July 10, 2025** |
| **Requested Time:** | **4:15 p.m. Eastern Time** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Helix Acquisition Corp. II and TheRas, Inc. together hereby request that the effective date of the above-captioned Registration Statement on Form S-4, as amended (the "Registration Statement"), be accelerated to, and that the Registration Statement be declared effective at 4:15 p.m., Eastern Time, on July 10, 2025, or as soon as practicable thereafter.

Please contact Joel Rubinstein (email: joel.rubinstein@whitecase.com or telephone: (212) 819-7642) of White & Case LLP or Maggie L. Wong (email: mwong@goodwinlaw.com or telephone: (415) 733-6071) of Goodwin Procter LLP with any questions and please notify one or more of them when this request for acceleration has been granted.

Very truly yours,

---

| | | | |
|:---|:---|:---|:---|
| TheRas, Inc. | TheRas, Inc. | Helix Acquisition Corp. II | Helix Acquisition Corp. II |
| By: | /s/ Eli Wallace | By: | /s/ Bihua Chen |
| Name: | Eli Wallace | Name: | Bihua Chen |
| Title: | Chief Executive Officer | Title: | Chief Executive Officer |

---

cc: Joel Rubinstein, White & Case LLP <br> Maggie L. Wong., Goodwin Procter LLP